SCHEMBL15828439

SCHEMBL15828439

CC(C)=C1CNCCCN1C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL86127 0.74 CHRM2 (0.35) —
SCHEMBL18650798 0.73 SLC6A2 (0.38) —
SCHEMBL85859 0.72 CHRM2 (0.34) —
SCHEMBL86171 0.71 CHRM2 (0.33) —
SCHEMBL18737180 0.71 CHRM2 (0.33) —
SCHEMBL18737181 0.71 CHRM2 (0.33) —
SCHEMBL18737193 0.71 CHRM2 (0.33) —
SCHEMBL19806778 0.69 CHRNA7 (0.32) —
SCHEMBL15828399 0.68 — —
SCHEMBL13960858 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9150592-B2 Heterocyclic nuclear hormone receptor modulators ABBVIE INC. (US) 2015-10-06 — — US disclosed
US-20140179676-A1 HETEROCYCLIC NUCLEAR HORMONE RECEPTOR MODULATORS ABBVIE INC. (US) 2014-06-26 — — US disclosed
Send feedback